Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOBR Safe, Inc. Director's Dealing 2020

Jan 14, 2020

35413_dirs_2020-01-14_770744af-4a68-4235-9baa-776a76fd3f3d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TransBiotec, Inc. (IMLE)
CIK: 0001425627
Period of Report: 2019-11-07

Reporting Person: Graham Gary John (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Common Stock Option $0.0079 2027-09-30 Common Stock (800000) Direct

Footnotes

F1: The Reporting Person owns options to acquire 800,000 shares of the Issuer's common stock, which option vests quarterly in equal installments over 2 years commencing on January 1, 2020. The options were issued on October 25, 2019 for consulting services provided to the Issuer by the Reporting Person.

F2: The options expire five years from their vesting date, with the last options expiring 9/30/2027.